Dr Marten is apparently on the sales block and HBA's Douglas Hand weighs in on the brand's valuation in this Footwear News article.
Douglas Hand, partner at the fashion law firm HBA, said a valuation like that would indeed be high, but, “That said, there are some real legacy elements to the brand that make it special. Notably its iconic relevance for decades that has seemed to be beyond trend/fashion cycles and its protectable trade dress (back tab, yellow welt stitching).”
You can read the rest of this article here: Taking Stock of the M&A Outlook for Shoe Brands: What’s Next for Dr. Martens, Cole Haan and Kurt Geiger?
Dr Marten is apparently on the sales block and HBA's Douglas Hand weighs in on the brand's valuation in this Footwear News article.
Douglas Hand, partner at the fashion law firm HBA, said a valuation like that would indeed be high, but, “That said, there are some real legacy elements to the brand that make it special. Notably its iconic relevance for decades that has seemed to be beyond trend/fashion cycles and its protectable trade dress (back tab, yellow welt stitching).”
You can read the rest of this article here: Taking Stock of the M&A Outlook for Shoe Brands: What’s Next for Dr. Martens, Cole Haan and Kurt Geiger?
.png)
.png)
